A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

but some drugs used to treat diabetes can make your cells more open or sensitive to insulin. They’re sometimes called insulin sensitizers. Two types, or classes, of diabetes drugs can improve ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes.

Breakthrough research into diabetes medications and stroke prevention Recent groundbreaking research has raised the possibility of a game-changing approach to stroke prevention. A study analyzing ...

“Diabetes has been considered as an incurable illness and is dependent on medication for [a] lifetime,” Xiaoying Li, MD, PhD, professor and director of the Department of Endocrinology and ...

Share on Pinterest An SGLT-2 inhibitor drug plus a moderately calorie-restrictive diet may be the best approach for achieving diabetes remission. Image credit: Xvision/Getty Images. About 828 ...

Eli Lilly posts robust Q4 earnings as Mounjaro and Zepbound sales more than double, lifting full-year revenue by 32% ...

Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either retrospective chart ...

Medically, Gestational (jes-TAY-shun-ul) Diabetes Mellitus (GDM ... with different values with small variations as shown in the chart below. You should initially consult with your obstetrician ...

Nearly 2 in 3 people who sought to lose weight quit popular weight loss and diabetes drugs such as Ozempic or Victoza within one year, according to a new study. About 65% of those without diabetes ...

Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after ...